GENEVA: The WHO Wednesday urged rich countries to pay their fair share of the money needed for its plan to conquer COVID-19 by contributing $16 billion as a matter of urgency.
The World Health Organization said the rapid cash injection into its Access to COVID Tools Accelerator could finish off Covid as a global health emergency this year.
The WHO-led ACT-A is aimed at developing, producing, procuring and distributing tools to tackle the pandemic: vaccines, tests, treatments and personal protective equipment.
ACT-A gave birth to the Covax facility, designed to ensure poorer countries could access eventual vaccines, correctly predicting that richer nations would hog doses coming off the production lines.
Covax delivered its billionth vaccine dose in mid-January.
ACT-A needed $23.4 billion for its programme for the year October 2021-September 2022 but only $800 million has been raised so far.
The scheme therefore wants $16 billion up front from wealthy nations “to close the immediate financing gap”, with the rest to be self-funded by middle-income countries.
Read more: Here’s how drinking black coffee aids in weight loss
WHO chief Tedros Adhanom Ghebreyesus said the rapid spread of the Omicron variant made it all the more urgent to ensure tests, treatments and vaccines are distributed equitably.
“If higher-income countries pay their fair share of the ACT-Accelerator costs, the partnership can support low- and middle-income countries to overcome low Covid-19 vaccination levels, weak testing, and medicine shortages,” he said in a statement.
“Science gave us the tools to fight COVID-19; if they are shared globally in solidarity, we can end COVID-19 as a global health emergency this year.”
Just 0.4 percent of the 4.7 billion COVID tests administered globally during the pandemic have been used in low-income countries.
